Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

790
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
790
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

3.0K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.0K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

729
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
729
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

278
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
278
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

825
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
825
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

227
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
227

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

One Block, Two Block, or More? Keep Counting.

Circulation·2026
Same author

Simplified Tools, Complex Decisions: These Are Rhythm Procedures: Why AF Ablation, Leadless Pacing, and Left Atrial Appendage Occlusion Require Rhythm-Centered Care.

Circulation. Arrhythmia and electrophysiology·2026
Same author

A Missed Signal and a Closed Pathway.

Circulation·2026
Same author

Liver-to-Atria Inflammatory Axis Driving Arrhythmia.

bioRxiv : the preprint server for biology·2026
Same author

The present and the future of risk stratification for and prevention of sudden cardiac death: A Heart Rhythm Society think tank meeting.

Heart rhythm·2026
Same author

Duration of antimicrobial therapy in cardiovascular implantable electronic device associated systemic infections: a retrospective analysis.

Therapeutic advances in infectious disease·2026
Same journal

Retraction: Jayne DRW et al. Avacopan for the Treatment of ANCA-Associated Vasculitis, N Engl J Med 2021;384:599-609.

The New England journal of medicine·2026
Same journal

Opportunities to Combat the Chronic Pain-Opioid Use Disorder Syndemic.

The New England journal of medicine·2026
Same journal

The Invisible Load of Cognitive Symptoms.

The New England journal of medicine·2026
Same journal

Phase 3 Trial of Oral Infigratinib in Children with Achondroplasia.

The New England journal of medicine·2026
Same journal

Cat Scratch Disease.

The New England journal of medicine·2026
Same journal

Declarations of Independence - Physicians and the U.S. Body Politic, 1776-2026.

The New England journal of medicine·2026
関連記事をすべて見る

関連する実験動画

Updated: Jan 23, 2026

Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach
07:49

Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach

Published on: July 21, 2023

1.9K

心不全における生理的ペーシング

Mihail G Chelu1,2,3, Jeanne E Poole4, Kenneth A Ellenbogen5

  • 1Section of Cardiology, Department of Medicine, Baylor College of Medicine, Houston.

The New England journal of medicine
|January 21, 2026
PubMed
まとめ
この要約は機械生成です。

心臓再同期療法（CRT）は、適格な患者において心不全の予後を改善する。ヒス束または左脚ブロックペーシングなどの代替ペーシング戦略が新たに登場しており、従来の二心室ペーシングと比較した有効性が調査中である。

キーワード:
心不全心臓再同期療法ペーシング生理的ペーシング両心室ペーシングヒス束ペーシング左脚ブロックペーシング

さらに関連する動画

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
12:45

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Published on: December 11, 2017

10.9K
Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
10:08

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine

Published on: February 17, 2018

13.9K

関連する実験動画

Last Updated: Jan 23, 2026

Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach
07:49

Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach

Published on: July 21, 2023

1.9K
Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
12:45

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Published on: December 11, 2017

10.9K
Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
10:08

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine

Published on: February 17, 2018

13.9K

科学分野:

  • 循環器学;医療機器;電気生理学

背景:

  • 心臓の生理的ペーシング、または心臓再同期療法（CRT）は、低駆出率と広いQRS幅を持つ心不全患者の治療法である。従来のCRTは、右心室リードと冠状静脈洞リードを使用した両心室ペーシングを含む。

研究 の 目的:

  • 心不全における両心室ペーシングの確立されたベネフィットをレビューする。ヒス束および左脚ブロックペーシングを含む、代替の生理的ペーシング戦略を紹介する。これらの新しい方法と従来のCRTを比較する進行中の研究を強調する。

主な方法:

  • 心不全における心臓ペーシングに関するランダム化試験および最近の研究のレビュー。臨床転帰、運動耐容能、生活の質、および心機能（LVEF、心室容積、僧帽弁逆流）の分析。

主要な成果:

  • 両心室ペーシングは、10,000人以上の心不全患者において、顕著な臨床的ベネフィットを示している。ベネフィットは、左脚ブロックおよびQRS幅≧150ミリ秒の患者で最も顕著である。伝導路ペーシング（ヒス束または左脚ブロック）は、実行可能な代替手段として登場している。

結論:

  • 両心室ペーシングは、選択された心不全患者の治療の根幹をなす。伝導路ペーシングは有望な代替手段を提供し、その比較有効性と安全性を確立するための試験が進行中である。個々の患者に最適なペーシング戦略を定義するには、さらなる研究が不可欠である。